Provided by Tiger Trade Technology Pte. Ltd.

JUNSHI BIO

17.710
-0.750-4.06%
Volume:4.78M
Turnover:84.20M
Market Cap:18.19B
PE:-20.36
High:18.300
Open:18.300
Low:17.350
Close:18.460
52wk High:38.640
52wk Low:15.250
Shares:1.03B
HK Float Shares:260.00M
Volume Ratio:1.48
T/O Rate:1.84%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.870
ROE:-9.32%
ROA:-2.23%
PB:2.62
PE(LYR):-20.36
PS:5.15

Loading ...

AH Share Premium Rankings as of April 6

Stock News
·
Apr 06

AH Share Premium Rankings for April 3

Stock News
·
Apr 03

China International Capital Corp. Highlights Positive Trends in Domestic Innovative Drug Sector, Anticipates Key Academic Developments in 2026

Stock News
·
Apr 03

JUNSHI BIO: March 2026 Monthly Return Confirms Stable Share Capital and No Share Movements

Bulletin Express
·
Apr 02

AH Share Premium Rankings as of April 1

Stock News
·
Apr 01

BRIEF-Shanghai Junshi Biosciences Says From 12 April 2025 To 31 March 2026, Chair Increased Stake

Reuters
·
Apr 01

Junshi Bio Chairman Concludes RMB100.64 Million Share Purchase; Controlling Group Stake Rises to 18.24%

Bulletin Express
·
Mar 31

Shanghai Junshi Biosciences - From 12 April 2025 to 31 March 2026, Chairman Increased Stake of Co by 3.3 Mln a,H Shares for RMB100.6 Mln

THOMSON REUTERS
·
Mar 31

JUNSHI BIO Sees 28% Revenue Growth, Yet Struggles to Close Nearly 10-Billion-Yuan Loss Gap

Deep News
·
Mar 25

Is It Time To Reassess Shanghai Junshi Biosciences (SEHK:1877) After Its Recent Share Price Strength

Simply Wall St.
·
Mar 22

Junshi Bio (01877/688180) Schedules 2025 Annual Results Briefing for 27 March 2026

Bulletin Express
·
Mar 20

Stock Track | Junshi Biosciences Soars 5.04% Intraday as Chairman Increases Stake

Stock Track
·
Mar 17

Junshi Biosciences' Chairman Raises Stake for 12 Million Yuan

MT Newswires Live
·
Mar 17

BRIEF-Shanghai Junshi Biosciences Says As At Mar 16, Controlling Shareholder Increased A Shares By 365,382 Shares For Total RMB12.2 Mln

Reuters
·
Mar 16

JUNSHI BIO Chairman Xiong Jun Increases Holdings by 365,400 A-Shares

Stock News
·
Mar 16

JUNSHI BIO Reports 28.23% Revenue Increase to RMB 2.5 Billion for 2025

Deep News
·
Mar 16

Shanghai Junshi Biosciences SEHK 1877 Valuation After Mixed Recent Share Performance And DCF Upside Potential

Simply Wall St.
·
Mar 15

Press Release: Junshi Biosciences Announces 2025 Full Year Financial Results and Provides Corporate Updates

Dow Jones
·
Mar 13

Junshi Bio (01877) posts RMB0.88 billion 2025 loss, skips dividend, sets RMB5.00 billion guarantee cap and taps up to RMB1.50 billion idle proceeds for liquidity

Bulletin Express
·
Mar 13

JUNSHI BIO Revamps Board Committee to Include ESG Oversight

Stock News
·
Mar 13